title: Genistein induces G2/M cell cycle arrest and apoptosis via ATM/p53-dependent pathway in human colon cancer cells.
abstract: Soybean isoflavones have been used as a potential preventive agent in anticancer research for many years. Genistein is one of the most active flavonoids in soybeans. Accumulating evidence suggests that genistein alters a variety of biological processes in estrogen-related malignancies, such as breast and prostate cancers. However, the molecular mechanism of genistein in the prevention of human colon cancer remains unclear. Here we attempted to elucidate the anticarcinogenic mechanism of genistein in human colon cancer cells. First we evaluated the growth inhibitory effect of genistein and two other isoflavones, daidzein and biochanin A, on HCT-116 and SW-480 human colon cancer cells. In addition, flow cyto-metry was performed to observe the morphological changes in HCT-116/SW-480 cells undergoing apoptosis or cell cycle arrest, which had been visualized using Annexin V-FITC and/or propidium iodide staining. Real-time PCR and western blot analyses were also employed to study the changes in expression of several important genes associated with cell cycle regulation. Our data showed that genistein, daidzein and biochanin A exhibited growth inhibitory effects on HCT-116/SW-480 colon cancer cells and promoted apoptosis. Genistein showed a significantly greater effect than the other two compounds, in a time- and dose-dependent manner. In addition, genistein caused cell cycle arrest in the G2/M phase, which was accompanied by activation of ATM/p53, p21waf1/cip1 and GADD45α as well as downregulation of cdc2 and cdc25A demonstrated by q-PCR and immunoblotting assay. Interestingly, genistein induced G2/M cell cycle arrest in a p53-dependent manner. These findings exemplify that isoflavones, especially genistein, could promote colon cancer cell growth inhibition and facilitate apoptosis and cell cycle arrest in the G2/M phase. The ATM/p53-p21 cross-regulatory network may play a crucial role in mediating the anticarcinogenic activities of genistein in colon cancer.
authors.affiliation: Tang Center for Herbal Medicine Research, University of Chicago, Chicago, IL 60637, USA.
authors.forename: Zhiyu
authors.initials: Z
authors.lastname: Zhang
authors.forename: Chong-Zhi
authors.initials: CZ
authors.lastname: Wang
authors.forename: Guang-Jian
authors.initials: GJ
authors.lastname: Du
authors.forename: Lian-Wen
authors.initials: LW
authors.lastname: Qi
authors.forename: Tyler
authors.initials: T
authors.lastname: Calway
authors.forename: Tong-Chuan
authors.initials: TC
authors.lastname: He
authors.forename: Wei
authors.initials: W
authors.lastname: Du
authors.forename: Chun-Su
authors.initials: CS
authors.lastname: Yuan
mesh_terms: D017209:Apoptosis / Q000187:drug effects; D064007:Ataxia Telangiectasia Mutated Proteins / Q000378:metabolism*; D059447:Cell Cycle Checkpoints / Q000235:genetics; D003110:Colonic Neoplasms / Q000188:drug therapy* / Q000473:pathology; D059565:G2 Phase Cell Cycle Checkpoints / Q000187:drug effects; D053263:Gene Regulatory Networks / Q000187:drug effects / Q000235:genetics; D019833:Genistein / Q000494:pharmacology*; D045325:HCT116 Cells; D006801:Humans; D007529:Isoflavones / Q000494:pharmacology; D013025:Glycine max / Q000737:chemistry; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism*; D020741:rho GTP-Binding Proteins
chemical_list: D007529:Isoflavones; C495901:TP53 protein, human; D016159:Tumor Suppressor Protein p53; C004742:daidzein; D019833:Genistein; C576324:ATM protein, human; D064007:Ataxia Telangiectasia Mutated Proteins; D020741:rho GTP-Binding Proteins; C004541:biochanin A